Cargando…

Psychiatric profile of motor subtypes of de novo drug‐naïve Parkinson's disease patients

BACKGROUND: Parkinson's disease (PD) is a heterogeneous neurodegenerative disorder. It is well established that different motor subtypes of PD evolve with different clinical courses and prognoses. The complete psychiatric profile underlying these different phenotypes since the very early stage...

Descripción completa

Detalles Bibliográficos
Autores principales:	Assogna, Francesca, Pellicano, Clelia, Cravello, Luca, Savini, Cinzia, Pierantozzi, Mariangela, Mercuri, Bruno, Caltagirone, Carlo, Pontieri, Francesco E., Spalletta, Gianfranco, Stefani, Alessandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6192407/ https://www.ncbi.nlm.nih.gov/pubmed/30160376 http://dx.doi.org/10.1002/brb3.1094

Ejemplares similares

Alexithymia and anhedonia in early Richardson's syndrome and progressive supranuclear palsy with predominant parkinsonism
por: Assogna, Francesca, et al.
Publicado: (2019)

Cognitive and Neuropsychiatric Profiles in Idiopathic Rapid Eye Movement Sleep Behavior Disorder and Parkinson’s Disease
por: Assogna, Francesca, et al.
Publicado: (2021)

Depressive symptoms in Parkinson’s disease and in non-neurological medical illnesses
por: Assogna, Francesca, et al.
Publicado: (2013)

Drug Choices and Advancements for Managing Depression in Parkinson's Disease
por: Assogna, Francesca, et al.
Publicado: (2020)

Blood Dendritic Cell Frequency Declines in Idiopathic Parkinson’s Disease and Is Associated with Motor Symptom Severity
por: Ciaramella, Antonio, et al.
Publicado: (2013)

Narrative discourse production in Parkinson’s disease: Decoupling the role of cognitive-linguistic and motor speech changes
por: D’Ascanio, Sara, et al.
Publicado: (2023)

Cerebellar GABA Levels and Cognitive Interference in Parkinson’s disease and Healthy Comparators
por: Piras, Federica, et al.
Publicado: (2020)

Immune System and Neuroinflammation in Idiopathic Parkinson’s Disease: Association Analysis of Genetic Variants and miRNAs Interactions
por: Strafella, Claudia, et al.
Publicado: (2021)

Frequency of Non-motor Symptoms in Parkinson's Patients With Motor Fluctuations
por: Fernandes, Mariana, et al.
Publicado: (2021)

Foot Pressure Wearable Sensors for Freezing of Gait Detection in Parkinson’s Disease
por: Marcante, Andrea, et al.
Publicado: (2020)

Prodromal non-motor symptoms of Parkinson’s disease
por: Pellicano, Clelia, et al.
Publicado: (2007)

Brain Functional Connectivity in de novo Parkinson's Disease Patients Based on Clinical EEG
por: Conti, Matteo, et al.
Publicado: (2022)

Effects of melatonin prolonged-release on both sleep and motor symptoms in Parkinson’s disease: a preliminary evidence
por: Liguori, Claudio, et al.
Publicado: (2022)

Both Motor and Non-Motor Fluctuations Matter in the Clinical Management of Patients with Parkinson’s Disease: An Exploratory Study
por: Carpi, Matteo, et al.
Publicado: (2023)

Cognitive and Affective Changes in Mild to Moderate Alzheimer’s Disease Patients Undergoing Switch of Cholinesterase Inhibitors: A 6-Month Observational Study
por: Spalletta, Gianfranco, et al.
Publicado: (2014)

Non-motor symptoms burden in motor-fluctuating patients with Parkinson’s disease may be alleviated by safinamide: the VALE-SAFI study
por: De Masi, Claudia, et al.
Publicado: (2022)

Gender specific decrease of a set of circulating N-acylphosphatidyl ethanolamines (NAPEs) in the plasma of Parkinson’s disease patients
por: Hamid, Zeeshan, et al.
Publicado: (2019)

Precision Medicine into Clinical Practice: A Web-Based Tool Enables Real-Time Pharmacogenetic Assessment of Tailored Treatments in Psychiatric Disorders
por: Zampatti, Stefania, et al.
Publicado: (2021)

Action Observation With Dual Task for Improving Cognitive Abilities in Parkinson’s Disease: A Pilot Study
por: Caligiore, Daniele, et al.
Publicado: (2019)

Commentary: Clinical Correlates of Raphe Serotonergic Dysfunction in Early Parkinson’s Disease
por: Liguori, Claudio, et al.
Publicado: (2015)

Subclinical Cognitive and Neuropsychiatric Correlates and Hippocampal Volume Features of Brain White Matter Hyperintensity in Healthy People
por: Spalletta, Gianfranco, et al.
Publicado: (2020)

Feasibility and Utility of mHealth for the Remote Monitoring of Parkinson Disease: Ancillary Study of the PD_manager Randomized Controlled Trial
por: Gatsios, Dimitris, et al.
Publicado: (2020)

Neurotrophins as Therapeutic Agents for Parkinson’s Disease; New Chances From Focused Ultrasound?
por: Stefani, Alessandro, et al.
Publicado: (2022)

Predictors of progression of cognitive decline in Alzheimer’s disease: the role of vascular and sociodemographic factors
por: Musicco, Massimo, et al.
Publicado: (2009)

The impact of extended release dopamine agonists on prescribing patterns for therapy of early Parkinson’s disease: an observational study
por: Pellicano, Clelia, et al.
Publicado: (2013)

Exploring the Association Linking Head Position and Sleep Architecture to Motor Impairment in Parkinson’s Disease: An Exploratory Study
por: Gnarra, Oriella, et al.
Publicado: (2023)

Speech and gait abnormalities in motor subtypes of de‐novo Parkinson's disease
por: Rusz, Jan, et al.
Publicado: (2023)

The Dopaminergic System in Peripheral Blood Lymphocytes: From Physiology to Pharmacology and Potential Applications to Neuropsychiatric Disorders
por: Buttarelli, Francesca R, et al.
Publicado: (2011)

Increased Noradrenaline as an Additional Cerebrospinal Fluid Biomarker in PSP-Like Parkinsonism
por: Cerroni, Rocco, et al.
Publicado: (2020)

Atrophy of presubiculum and subiculum is the earliest hippocampal anatomical marker of Alzheimer's disease
por: Carlesimo, Giovanni A., et al.
Publicado: (2015)

Comparison of Three Motor Subtype Classifications in de novo Parkinson's Disease Patients
por: Ren, Jingru, et al.
Publicado: (2020)

Consistency and Stability of Motor Subtype Classifications in Patients With de novo Parkinson’s Disease
por: Ren, Jingru, et al.
Publicado: (2021)

Structural and functional differences of the thalamus between drug-naïve Parkinson’s disease motor subtypes
por: Chen, Yubing, et al.
Publicado: (2023)

Anti-inflammatory Effects of Homotaurine in Patients With Amnestic Mild Cognitive Impairment
por: Bossù, Paola, et al.
Publicado: (2018)

Not just a Snapshot: An Italian Longitudinal Evaluation of Stability of Gut Microbiota Findings in Parkinson’s Disease
por: Cerroni, Rocco, et al.
Publicado: (2022)

STN-DBS Induces Acute Changes in β-Band Cortical Functional Connectivity in Patients with Parkinson’s Disease
por: Conti, Matteo, et al.
Publicado: (2022)

Polygenic determinants of white matter volume derived from GWAS lack reproducibility in a replicate sample
por: Papiol, S, et al.
Publicado: (2014)

Myeloid Dendritic Cells are Potential Players in Human Neurodegenerative Diseases
por: Bossù, Paola, et al.
Publicado: (2015)

Effectiveness of a Family Support Intervention on Caregiving Burden in Family of Elderly Patients With Cognitive Decline After the COVID-19 Lockdown
por: Cravello, Luca, et al.
Publicado: (2021)

Adult-onset sporadic chorea: real-world data from a single-centre retrospective study
por: Bovenzi, Roberta, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ae3fhk47npsem4odaplara1c62